Friday, September 25, 2026 Never miss a recall or a rule change Get the free brief →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
Devices & TechECHOLASER X4 Clears FDA 510(k) for General Surgerylast weekBusiness & M&AAbbVie Files Material Event—Allē Rebate Terms Shifting7 weeks agoDevices & TechVIOL Scarlet Pro Wins FDA 510(k) Clearance2 weeks agoComplianceEvolus Rewards Program Terms Changed—Review Now7 weeks agoDevices & TechHebei Zollvan Diode Laser Clears FDA 510(k)2 weeks agoBusiness & M&ARejuran Maker PharmaResearch Acquires Cosmetic Group5 weeks agoBusiness & M&AAbbVie Files Material Event: Botox/Juvéderm Pricing Shift3 weeks agoBusiness & M&AAbbVie Files Material Event on Allergan Aesthetics5 weeks agoSearch DemandWho Can Inject Botox and Filler in Florida: Scope of Practice and Licensure Requirements4 weeks agoMarketGLP-1 Pill Era Is Forcing Beauty Market Shift5 weeks agoSearch DemandMedical Spa Revenue Calculator: Model Your Practice Economics4 weeks agoSearch DemandGood Faith Exam for Med Spas: State Requirements, Scope, and Compliance4 weeks ago
Devices & Tech

Lease vs Finance vs Buy on a $120K Platform: The Tax and Cash-Flow Math Reps Won't Show You

The rep is incentivized toward whichever structure closes today. The right answer depends on your cash position, your tax situation, and how fast the technology obsoletes — none of which are on their brochure.

A serene spa session capturing wellness and relaxation with a therapist attending to a client.
Photo: Lespa số 1 về điều trị mụn, nám, sẹo rỗ / Pexels

Get the free Inside MedSpa brief by email

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

A $120,000 platform never gets sold as $120,000. It gets sold as "less than the cost of one treatment a day" — a monthly payment engineered to feel small enough that the total disappears from view. That framing isn't dishonest, exactly. It's just optimized for the rep's actual product, which is not a device but a payment small enough to close today. Your job is to look underneath the payment at the three things that actually determine the right financing structure, none of which fit on a brochure: your cash position, your tax situation, and the speed at which the technology will obsolete.

This is general business education, not tax advice. The depreciation and tax treatment below depend on your specific situation and current law — run the actual numbers with your accountant before you sign.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

ComparedBuy OutrightFinance (Loan)
Cash outlay upfrontFull $120K due at purchaseDown payment (varies); rest financed
Working capital impactDepletes cash reserves immediatelyPreserves working capital; monthly payments
Ownership & depreciationYou own asset; full depreciation benefitYou own asset; full depreciation benefit; plus interest deduction
Total cost over term$120K + opportunity cost$120K + interest premium
Flexibility / upgrade pathLocked in; must sell or abandon to exitLocked in; must pay off or refinance to exit
Best forStrong cash position; long platform life; tax appetiteSolid cash flow; want to preserve reserves; confident in platform longevity
Obsolescence riskYou bear full risk if tech moves faster than expectedYou bear full risk; locked into payments regardless
Bottom line: Buy outright if you have excess cash and expect the platform to have a long useful life; finance if you want ownership and tax benefits but need to preserve working capital for operations and growth.
Reps don't sell devices; they sell monthly payments small enough to feel like nothing. Your job is to look past the payment to the total cost and the tax treatment underneath it.

The three structures, honestly

Buying outright maximizes total-cost efficiency — you pay no financing premium — and gives you a depreciable asset that may carry favorable tax treatment. The cost is cash: every dollar in the platform is a dollar not available for staffing, marketing, or the next opportunity. Buying is strongest when you have cash to spare, a tax appetite for the depreciation, and confidence the platform has a long useful life.

Financing (a loan against the equipment) preserves cash while still giving you ownership and the associated depreciation, at the cost of interest. It's the middle path: you keep working capital, you own the asset, you pay a premium for the privilege. It fits when the device is a keeper but you'd rather not drain the bank account to own it.

Leasing preserves the most flexibility and can shift obsolescence risk, typically at the highest total cost over the term. Its real value shows up with fast-moving technology — a category where you expect to want to upgrade in a few years. Paying a premium to keep the option to swap into the next platform can be entirely rational when the alternative is owning a depreciating machine nobody's asking for anymore.

The tax layer the payment hides

Here's where the monthly-payment framing does the most damage: it pulls your attention away from the after-tax cost, which can differ meaningfully across structures. Purchased equipment may qualify for accelerated depreciation that changes the real, tax-adjusted cost of buying versus leasing — sometimes enough to flip the decision. Because that treatment depends on your entity, your income, and current law, it's a conversation to have with your accountant before you choose a structure, not a detail to reconcile at tax time after the rep has already booked the deal.

The point isn't that one structure is always more tax-efficient. It's that you cannot know which is right for you without doing the after-tax math, and the payment-centric pitch is specifically designed to keep you from doing it.

Let obsolescence speed pick the structure

Tie it together with one question: how long will this platform be the thing patients want? In aesthetics, that horizon is often shorter than the financing term, because the category moves. If you genuinely expect to keep and run a workhorse platform for many years, ownership (buy or finance) usually wins on total cost. If you're buying into a fast-moving category you'll want to refresh, the flexibility of a lease can be worth its premium. Matching the structure to the obsolescence clock is the single most useful discipline in the decision.

What to do

  • Convert every pitch back to total cost of ownership and after-tax cost. Make the rep's monthly number the last thing you look at, not the first.
  • Take the structure decision to your accountant before signing. The depreciation and tax treatment can move the answer, and that conversation belongs upstream of the contract.
  • Match structure to obsolescence. Own the workhorses; lease the platforms you expect to outgrow.
  • Protect your working capital deliberately. The cheapest total cost isn't worth much if buying outright leaves you unable to staff or market the device you just bought.

The device is the same machine whether you lease, finance, or buy it. What changes is your cash, your tax bill, and your flexibility — the three things the monthly-payment pitch is built to keep you from comparing. Compare them, with your accountant, and the right structure becomes obvious. Skip it, and you'll have optimized for the rep's quarter instead of your balance sheet.

Frequently asked questions

Is it better to lease, finance, or buy an aesthetic device?

It depends on three things: your available cash and what else that cash could do, your tax situation and whether you can use accelerated depreciation, and how fast the platform will obsolete. There's no universal answer — the right structure is the one that fits your balance sheet and your time horizon, which is exactly what a rep's payment-focused pitch obscures. Consult your accountant.

Why might leasing make sense for fast-moving technology?

Leasing can shift obsolescence risk and preserve flexibility to upgrade when a category moves quickly, at the cost of typically paying more over the full term. For a platform you expect to want to replace in a few years, that flexibility can be worth the premium.

What's the tax angle owners overlook?

Purchased equipment may qualify for accelerated depreciation that can meaningfully change the after-tax cost of buying versus leasing. Because the tax treatment differs by structure and by your specific situation, this is a conversation for your accountant before you sign — not after.

Why do reps push monthly-payment framing?

Because a small monthly number lowers buying resistance far more than a large total. The payment is real, but it's designed to keep your attention off the total cost of ownership and the tax-adjusted comparison, where the actual decision lives.

Business information, not medical or legal advice. Verify product status at FDA.gov.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.

Share

https://insidemedspa.com/article/device-lease-vs-finance-vs-buy/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa · Free brief

    By the time it's news, it's too late.

    FDA decisions, recalls and the rules you operate under, drafted from the source documents and sent free by email.

    Get the free brief The free Inside MedSpa brief · no card · unsubscribe anytime.
    FDA, recalls and rule changes for practice owners Get the free brief →